Histopathological Efficacy of Docetaxel Versus Paclitaxel As First Line Chemotherapy for Epithelial Ovarian Carcinoma

Authors

  • Tayyup Şimşek Department of Obstetrics and Gynecology Division of Gynecologic Oncology, Akdeniz University Faculty of Medicine, Antalya
  • Arif Yılmaz Department of Obstetrics and Gynecology Division of Gynecologic Oncology, Akdeniz University Faculty of Medicine, Antalya
  • Gülgün Erdoğan Department of Pathology, Akdeniz University Faculty of Medicine, Antalya
  • Elif Peştereli Department of Pathology, Akdeniz University Faculty of Medicine, Antalya

Keywords:

Paclitaxel, Docetaxel, Ovarian cancer

Abstract

OBJECTIVE: To evaluate and compare efficacy of docetaxel and paclitaxel combining with carboplatin in the first line chemotherapy of epithelial ovarian carcinoma according to hystopathological findings of second look laparatomy.
STUDY DESIGN: Thirty two patients having stage II-IV epithelial ovarian cancer (17 cases in the paclitaxel-carboplatin group,15 cases in the docetaxel-carboplatin group) and operated in Department of Obstetrics and Gynecology, Division of Gynecologic Oncology were entered in this study. The cases were randomized for the treatment. All cases had inform-consent about the treatment options and second
look procedures. The cases who completed chemotherapy and had a second look laparatomy were included the study. Pathological responses were evaluated with second look findings proved with biopsy. Statistical analyses were performed with Chi square and Mann-Whitney U tests. Survival analyses were calculated with using Kaplan-Meier survival analyses and Log Rank test. P>0.05 was accepted for statistical significance.
RESULTS: There were no differences in demographic characteristics and rate of optimal cytoreduction between two groups. Eight cases (47,1%) in the paclitaxel-carboplatin group and 3 cases (20%) in the docetaxel-carboplatin group were hystopathological tumor positive in the second look operation without statistically significance. Also there was no significant difference between two groups in mean survival time(p 0.06).
CONCLUSION: Efficacy of docetaxel and paclitaxel are the same in terms of hystopathological findings of second look laparatomy in the treatmet of first-line epithelial ovarian cancer.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2008-12-27

How to Cite

1.
Şimşek T, Yılmaz A, Erdoğan G, Peştereli E. Histopathological Efficacy of Docetaxel Versus Paclitaxel As First Line Chemotherapy for Epithelial Ovarian Carcinoma. Gynecol Obstet Reprod Med [Internet]. 2008Dec.27 [cited 2022May28];14(3):189-92. Available from: https://gorm.com.tr/index.php/GORM/article/view/470

Issue

Section

Gynecology and Gynecological Oncology